Company page

Hem Pharma, Inc.

Hem Pharma, Inc. is a publicly traded company on the Korean market under the ticker 376270. The company has a market capitalization of approximately 242 million USD. Hem Pharma focuses on developing innovative pharmaceutical solutions to meet various healthcare needs.

profile376270AI content: aiUpdated May 30, 2026/company/hem-pharma-inc
Hem Pharma, Inc. logo
Ticker
376270
Market cap
$242.0M
Sector
Health Technology
Industry
Biotechnology